1.Research advances in tissue engineering bionic periosteum for bone repair
Hao WEI ; Kaiyong CAI ; Yan HU
Chinese Journal of Orthopaedics 2025;45(20):1341-1347
Functionalized tissue-engineered biomimetic periosteum has similar functions and structures to natural periosteum, can enhance bone regeneration function, and is expected to become a direct substitute for natural periosteum. Inorganic materials such as hydroxyapatite, tricalcium phosphate, and bioactive glass graphene oxide were prepared into nanoparticles, nanowires, microspheres, etc., and combined with natural materials to introduce them into tissue-engineered periosteum, which effectively improved the mechanical properties of natural materials and delayed the degradation of implants. In addition, elements such as calcium and phosphorus in inorganic materials have chemical similarities to natural bones and can mediate the microenvironment to promote bone and blood vessel regeneration, thereby facilitating bone healing. The construction of vascularized and neuralized tissue-engineered periosteum not only promotes the framework of bone regeneration but also provides support for blood vessels and nerves, thereby accelerating the bone healing process and enhancing the bone tissue repair capacity. The composite scaffold system carrying fibroblast growth factor with gelatin hydrogel as the carrier has demonstrated excellent dual effects of promoting angiogenesis and bone repair.
2.Research advances in tissue engineering bionic periosteum for bone repair
Hao WEI ; Kaiyong CAI ; Yan HU
Chinese Journal of Orthopaedics 2025;45(20):1341-1347
Functionalized tissue-engineered biomimetic periosteum has similar functions and structures to natural periosteum, can enhance bone regeneration function, and is expected to become a direct substitute for natural periosteum. Inorganic materials such as hydroxyapatite, tricalcium phosphate, and bioactive glass graphene oxide were prepared into nanoparticles, nanowires, microspheres, etc., and combined with natural materials to introduce them into tissue-engineered periosteum, which effectively improved the mechanical properties of natural materials and delayed the degradation of implants. In addition, elements such as calcium and phosphorus in inorganic materials have chemical similarities to natural bones and can mediate the microenvironment to promote bone and blood vessel regeneration, thereby facilitating bone healing. The construction of vascularized and neuralized tissue-engineered periosteum not only promotes the framework of bone regeneration but also provides support for blood vessels and nerves, thereby accelerating the bone healing process and enhancing the bone tissue repair capacity. The composite scaffold system carrying fibroblast growth factor with gelatin hydrogel as the carrier has demonstrated excellent dual effects of promoting angiogenesis and bone repair.
3.Application of chemogenetic technology in the study of neural circuits in depression
Shaowei LI ; Jiehui LI ; Mingkuan ZHANG ; Hao ZHANG ; Minghui HU ; Dan CHEN ; Kaiyong XU ; Zifa LI ; Xiwen GENG ; Sheng WEI
Chinese Journal of Behavioral Medicine and Brain Science 2024;33(6):554-559
Chemogenetic technology is a receptor-ligand system that regulates cell viability and function by changing receptor specificity and affinity, and it achieves precise neuronal regulation by specifically regulating neurons and neural circuits. At present, this technique is widely used in the study of neural circuits. This article briefly describes the application and progress of chemogenetic technology in the study of depression neural circuits, reviews the application of chemogenetic technology in several brain regions closely related to depression, such as ventral tegmental area, nucleus accumbens, prefrontal cortex, hippocampus and lateral habenula, and discusses the potential and challenges of chemogenetic technology as a technology for precise regulation of neural activity in future research, in order to provide reliable ideas and directions for chemogenetic technology in the study of depression neural circuits.
4.Cost-effectiveness of pharmaceutical smoking cessation intervention in China primary cancer prevention
Peiyuan SUN ; Yuting XIE ; Ranran QIE ; Huang HUANG ; Zhuolun HU ; Mengyao WU ; Qi YAN ; Cairong ZHU ; Jufang SHI ; Kaiyong ZOU ; Yawei ZHANG
Chinese Journal of Oncology 2024;46(1):66-75
Objectives:To evaluate the cost-effectiveness of typical pharmaceutical smoking cessation intervention strategies in China in the context of primary cancer prevention.Methods:Markov cohort simulation models were established to simulate the burden of 12 smoking caused cancer, including lung cancer, oral cancer, nasopharyngeal cancer, laryngeal cancer, esophageal cancer, gastric cancer, pancreatic cancer, liver cancer, kidney cancer, bladder cancer, cervical cancer, and acute myeloid leukemia. Taking incremental cost effectiveness ratio (ICER) as the main indicator, the model sets one year as the cycling period for 50 periods and simulates the cohort of 10 000 thirty-five-year-old current smokers with various smoking cessation strategies. To ensure the robustness of conclusion, univariate sensitivity analysis, probability sensitivity analysis, and age-group sensitivity analysis were conducted.Results:The results showed that varenicline intervention was the most cost-effective intervention. Compared to the next most effective option, incremental cost of each additional quality-adjusted life year is 11 140.28 yuan, which is below the threshold of willingness to pay (1 year GDP per capita). The value of ICER increased as the increasing age group of adopting intervention, but neither exceeded the threshold of willingness to pay. One-way sensitivity analysis showed that the value of discount rate, the hazard ratio and cost of intervention strategy had a greater impact on the result of ICER.Conclusion:In China, the use of varenicline to quit smoking is highly cost effective in the context of cancer primary prevention, especially for younger smokers.
5.The past,present,and future of in vivo-implant-able recording microelectrodes:the neural interfaces
Kun LIU ; Hao ZHANG ; Minghui HU ; Zifa LI ; Kaiyong XU ; Dan CHEN ; Wenqiang CUI ; Cui LYU ; Ran DING ; Xiwen GENG ; Sheng WEI
Chinese Journal of Pharmacology and Toxicology 2023;37(7):553-553
Neural recording electrodes enable the acquisition and collection of electrical signals from neu-rons,and these recorded neural electrical signals are an important means of understanding neuronal activity.As a major component of the brain-machine interface,neu-ral recording electrodes serve as a bridge between the nervous system and external devices.The extracted information can be used to understand the state of the brain and acts as a feedback signal to regulate external devices,thus providing important information for the clini-cal treatment of neurological diseases.Moreover,the electrodes can be used as a vehicle for drug injection to directly treat diseases.Since the time that Strumwas-ser used microwires to achieve long-term recordings of neural activity in hibernating squirrels,implantable elec-trode technology has gradually improved over three gen-erations of development,and progress has been made in improving the biocompatibility,mechanical performance(size,shape,density,etc.),and signal-to-noise ratio.Implantable neural recording electrodes can acquire sig-nals from cortical and deep neural clusters,with the advantages of high signal-to-noise ratio,information con-tent,and spatial/temporal resolution.However,there is still a need to improve the structure and performance of these electrodes;for example,their high invasiveness and lack of biocompatibility pose technical difficulties in the process of translation to the clinic.This paper reviews the basic requirements for electrodes,main recording methods and signal types,common types of implant-able neural recording electrodes,and their challenges and future development directions.With the continuous development of electrode materials,equipment,systems,and neurotechnology,it should be possible to apply neu-ral recording electrodes in clinical practice,to promote safe and efficient treatment of human diseases.
6.Immunotoxicity of absorbable silk fibroin biofilm on rats
Xiaoling XU ; Wangping PAN ; Xiaojun LÜ ; Ju ZHANG ; Yuanhua HU ; Kaiyong HE
Chinese Journal of Tissue Engineering Research 2019;23(14):2190-2195
BACKGROUND: Silk fibroin, the main component of silk fibroin biofilm, is a natural protein, but it is still a heterologous protein to the body. Its immunogenicity/toxicity is an important factor in determining the development prospects. OBJECTIVE: To evaluate the toxicity of absorbable silk fibroin biofilm and its degradation products on the rat immune system by muscle implantation experiments in rats. METHODS: Ten Wistar rats from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. were implanted with a long strip of 1 mm× 10 mm in the right gluteal muscle to observe the implant absorption and determine the implantation cycle. Seventy-two Wistar rats were assigned into control and experimental groups (n=36/group, 18 in either sexes) . A long strip of 1 mm×10 mm was implanted into the rat right gluteal muscle in the experimental group, and the control group received no implantation. Some of the rats were taken for histological examination and calculate the organ/weight ratio, at 26 weeks postoperatively. The spleen lymphocyte proliferation ability, NK cell activity, cell classification of T lymphocytes, and levels of interleukin 2 and tumor necrosis factor α were detected. Another part of the animals was taken for macrophage phagocytosis of erythrocytes cell capacity and antibody producing cell count. RESULTS AND CONCLUSION: (1) Silk fibroin biofilm was completely absorbed after implanted into the rat muscle for 26 weeks. (2) In female or male Wistar rats, the immune organs in the experimental group showed no significant changes in the appearance, weight and histological examination. There were no significant differences in the hematological indexes (hemoglobin, red blood cell count, hematocrit, blood platelet count and white blood cell count and classification) , spleen lymphocyte proliferation, NK cell activity, the ratio of T lymphocytes and their subpopulations, and the levels of interleukin 2 and tumor necrosis factor α had no significant differences between two groups (P> 0.05) . (3) In female or male Wistar rats, the macrophage phagocytosis of chicken erythrocytes cell capacity and antibody producing cell count showed no significant differences between two groups (P> 0.05) . (4) These results indicate that silk fibroin biofilm causes no immunosuppression or immunostimulation on immune organs, immune cells and immune molecules (cytokines) of rats.
7.Determination of Copper Ion in Rabbit with Implantation of Copper Intrauterine Device
Xiaoling XU ; Kaiyong HE ; Wangping PAN ; Xiaojun LYU ; Yuanhua HU
Herald of Medicine 2017;36(6):614-616
Objective To develop a method for determination of serumal copper ion in rabbit with implantation of copper intrauterine device.Methods At different time points after implantation,the serumal copper ion concentrations were determined by microwave digestion-inductively coupled plasma mass spectrometry(ICP-MS) using scandium(Sc) and indium(In) as internal standards to compensate sample matrix effects,and the pharmacokinetics parameters were calculated in order to reflect copper ion release and metabolic rule.Results The serumal copper ion concentrations were kept at a low and stable level.The recoveries were in the range of 98.7%-113.3%,with the relative standard deviations of less than 5.0%.Conclusion The analytical method is simple,fast,and can be used for the determination of serumal copper ion in rabbit.
8.The understanding of Epstein-Barr virus associated lymphoproliferative disorder
Xiaoge ZHOU ; Yanlin ZHANG ; Jianlan XIE ; Yuhua HUANG ; Yuanyuan ZHENG ; Wensheng LI ; Hao CHEN ; Fang LIU ; Huaxiong PAN ; Ping WEI ; Zhe WANG ; Yuchang HU ; Kaiyan YANG ; Hualiang XIAO ; Meijuan WU ; Weihua YIN ; Kaiyong MEI ; Gang CHEN ; Xiaochu YAN ; Gang MENG ; Gang XU ; Juan LI ; Sufang TIAN ; Jun ZHU ; Yuqin SONG ; Weijing ZHANG
Chinese Journal of Pathology 2016;45(12):817-821
In recent years , there are increasing articles concerning Epstein-Barr virus associated lymphoproliferative disorder (EBV+LPD), and the name of EBV +LPD is used widely.However,the meaning of EBV+LPD used is not the same , which triggered confusion of the understanding and obstacles of the communication.In order to solve this problem.Literature was reviewed with combination of our cases to clarify the concept of EBV +LPD and to expound our understanding about it .In general, it is currently accepted that EBV +LPD refers to a spectrum of lymphoid tissue diseases with EBV infection , including hyperplasia , borderline lesions , and neoplastic diseases .According to this concept , EBV+LPD should not include infectious mononucleosis ( IM ) and severe acute EBV infection ( EBV +hemophagocytic lymphohistiocytosis, fatal IM, fulminant IM, fulminant T-cell LPD), and should not include the explicitly named EBV+lymphomas ( such as extranodal NK/T cell lymphoma , aggressive NK cell leukemia , Burkitt lymphoma, and Hodgkin lymphoma , etc.) either.EBV +LPD should currently include: ( 1 ) EBV +B cell-LPD:lymphomatoid granulomatosis , EBV +immunodeficiency related LPD , chronic active EBV infection-B cell type, senile EBV +LPD, etc.(2) EBV +T/NK cell-LPD:CAEBV-T/NK cell type, hydroa vacciniforme, hypersensitivity of mosquito bite, etc.In addition, EBV+LPD is classified, based on the disease process , pathological and molecular data , as 3 grades:grade1, hyperplasia ( polymorphic lesions with polyclonal cells ); grade 2, borderline ( polymorphic lesions with clonality ); grade 3, neoplasm (monomorphic lesions with clonality).There are overlaps between EBV +LPD and typical hyperplasia, as well as EBV+LPD and typical lymphomas .However , the most important tasks are clinical vigilance , early identification of potential severe complications , and treating the patients in a timely manner to avoid serious complications , as well as the active treatment to save lives when the complications happened .
9.Study of the Intestinal Absorption Mechanism of Galangin in Rats
Junlin HU ; Tao YANG ; Kaiyong HE
Herald of Medicine 2015;(5):612-616
Objective To investigate the absorption characteristics of galangin in various intestinal segments. Methods Single-pass intestinal perfusion was employed in rats, and the mass quality was used to correct the volume;Galangin in rat intestinal perfusion was determined by HPLC to investigate the effects of intestinal segments, drug concentration and P-glycoprotein ( P-gp) inhibitor on drug’ s absorption. Results Galangin could be absorbed in the whole intestine, and its Ka values in the segments of duodenum, jejunum, ileum and colon were (5. 12±1. 14)í10-2,(2. 23±1. 02)í10-2,(4. 61± 0. 75)í 10-2 and(2. 68 ± 0. 70)í10-2 ·min-1 ,respectively. Meanwhile, the values of the Ka in the segment of ileum were not affected by the drug concentration and P-gp inhibitor. Conclusion The galangin is well absorbed in rats intestinal segments. The absorption procedure is mainly controlled by passive diffusion but unaffected by P-gp efflux protein.
10.Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B.
Kaiyong HU ; Yong YANG ; Lihua HE ; Duowei WANG ; Zhirong JIA ; Shuran LI ; Wei TIAN ; Jie MAO ; Xianjing LI ; Wei ZHANG
Acta Pharmaceutica Sinica 2014;49(7):1007-12
In this study, it is to compare the effectiveness of prevention against and treatment of doxorubicin (DOX) induced cardiotoxicity by dexrazoxane and schisandrin B (Sch B) in rats. Sprague-Dawley (SD) rats were randomly divided into the following 6 groups: normal saline group, DOX group, DOX+DEX group, DOX+Sch B (80 mg x kg(-1)) group, DOX+Sch B (40 mg x kg(-1)) group and DOX+Sch B (20 mg x kg(-1)) group. The results showed that Sch B could combat the increase of myocardial enzymes in peripheral blood, decrease of the enzyme activity of myocardial tissue antioxidant enzymes and disorders of systolic and diastolic function of heart in rats intravenously injected with doxorubicin (15 mg x kg(-1)). Sch B was better than DEX in protecting rat against DOX-induced the symptoms. Sch B could protect rat against DOX-induced acute cardiomyopathy and has clinical potential applications.

Result Analysis
Print
Save
E-mail